Fumonisin B1 is a mycotoxin produced by Fusarium moniliforme that has been shown to potently inhibit sphingosine N-acyltransferase, thereby disrupting the synthesis of sphingolipids, a key component of plasma membranes.
This report contains market size and forecasts of Fumonisin B1 in global, including the following market information:
Global Fumonisin B1 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Fumonisin B1 Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Fumonisin B1 companies in 2021 (%)
The global Fumonisin B1 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fumonisin B1 include Adooq Bioscience, LKT Laboratories, Abcam, Spectrum Chemical, StressMarq Biosciences, Biosynth Carbosynth, LGC, Cayman Chemical and Santa Cruz Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fumonisin B1 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fumonisin B1 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Fumonisin B1 Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Fumonisin B1 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Fumonisin B1 Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Fumonisin B1 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Fumonisin B1 Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fumonisin B1 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Fumonisin B1 revenues share in global market, 2021 (%)
Key companies Fumonisin B1 sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Fumonisin B1 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adooq Bioscience
LKT Laboratories
Abcam
Spectrum Chemical
StressMarq Biosciences
Biosynth Carbosynth
LGC
Cayman Chemical
Santa Cruz Biotechnology
Bio-Techne
Merck
Enzo Biochem
Focus Biomolecules
STEMCELL Technologies
APExBIO Technology
Pharmaffiliates
Cato Research Chemicals
Aladdin